Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma - Concepedia

Concepedia

Publication | Open Access

Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma

DOI Full Paper Access

124

Citations

25

References

2009

Year

Niels Smedegaard Andersen, Lone Bredo Pedersen, Anna Laurell, Erkki Elonen, Arne Kolstad, Anne Marie Boesen, Lars Møller Pedersen, Grete F. Lauritzsen, Roald Ekanger, Herman Nilsson‐Ehle,

Journal of Clinical Oncology

Abstract

Molecular relapse may occur many years after ASCT in MCL, and PCR based pre-emptive treatment using rituximab is feasible, reinduce molecular remission, and may prevent clinical relapse.

References

	Year	Citations

Page 1